These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 15182338

  • 1. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    Cesaro S, Toffolutti T, Messina C, Calore E, Alaggio R, Cusinato R, Pillon M, Zanesco L.
    Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
    [Abstract] [Full Text] [Related]

  • 2. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.
    Yilmaz D, Balkan C, Ay Y, Akin M, Karapinar B, Kavakli K.
    Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090
    [Abstract] [Full Text] [Related]

  • 3. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.
    Vagace JM, Sanz-Rodriguez C, Casado MS, Alonso N, Garcia-Dominguez M, de la Llana FG, Zarallo L, Fajardo M, Bajo R.
    BMC Infect Dis; 2007 May 10; 7():40. PubMed ID: 17493279
    [Abstract] [Full Text] [Related]

  • 4. Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.
    Castagnola E, Machetti M, Cappelli B, Molinari AC, Morreale G, Dodero P, Tomà P, Faraci M.
    Clin Microbiol Infect; 2004 Mar 10; 10(3):255-7. PubMed ID: 15008948
    [Abstract] [Full Text] [Related]

  • 5. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T, Ozkalemkaş F, Kocaeli H, Altundal Y, Ener B, Ali R, Ozkocaman V, Hakyemez B, Tunali A.
    Mikrobiyol Bul; 2009 Jul 10; 43(3):499-506. PubMed ID: 19795628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.
    N Engl J Med; 2004 Sep 30; 351(14):1391-402. PubMed ID: 15459300
    [Abstract] [Full Text] [Related]

  • 8. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
    Aliff TB, Maslak PG, Jurcic JG, Heaney ML, Cathcart KN, Sepkowitz KA, Weiss MA.
    Cancer; 2003 Feb 15; 97(4):1025-32. PubMed ID: 12569602
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach.
    Ament AJ, Hübben MW, Verweij PE, de Groot R, Warris A, Donnelly JP, van 't Wout J, Severens JL.
    J Antimicrob Chemother; 2007 Aug 15; 60(2):385-93. PubMed ID: 17561501
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb 15; 13(69):13-6. PubMed ID: 15055210
    [Abstract] [Full Text] [Related]

  • 13. Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
    Rösen-Wolff A, Koch A, Friedrich W, Hahn G, Gahr M, Roesler J.
    Pediatr Infect Dis J; 2004 Jun 15; 23(6):584-6. PubMed ID: 15194848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia.
    Madero L, Sanchez de Toledo J, Castel V, Sevilla J, Gonzalez-Esteban J, Sanz-Rodriguez C.
    J Chemother; 2009 Apr 15; 21(2):229-31. PubMed ID: 19423481
    [No Abstract] [Full Text] [Related]

  • 16. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW, Kuijper EJ, Verweij PE, Kullberg BJ.
    Ned Tijdschr Geneeskd; 2004 Aug 21; 148(34):1679-84. PubMed ID: 15453120
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Concentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.
    Meletiadis J, Stergiopoulou T, O'Shaughnessy EM, Peter J, Walsh TJ.
    Antimicrob Agents Chemother; 2007 Jun 21; 51(6):2053-64. PubMed ID: 17387150
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.